Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583284 · ClinicalTrials.gov registry record
The Use of CT to Identify Damaged Heart Muscle in Patients Undergoing Ventricular Tachycardia Ablation.
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 4
- Enrollment target
NCT00583284 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 4 participants.
The verdict
NCT00583284 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Patients with ventricular tachycardia (VT) undergo catheter ablation. During the ablation procedure, the heart is mapped to determine areas of heart muscle damage. The heart scarring areas are often the source of the VT. Delayed enhancement CT has recently been used to determine areas of scarring . This study is to determine if the areas of damaged heart muscle mapped with the delayed enhancement CT correlate with the same areas that are determined during the catheter ablation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583284
The ClinicalTrials.gov registry entry for NCT00583284 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00583284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00583284 about?
NCT00583284 is a clinical study titled "The Use of CT to Identify Damaged Heart Muscle in Patients Undergoing Ventricular Tachycardia Ablation.". Patients with ventricular tachycardia (VT) undergo catheter ablation. During the ablation procedure, the heart is mapped to determine areas of heart muscle damage. The heart scarring areas are often the source of the VT. Delayed enhancement CT has recently been used to determine areas of scarring . ...
What is the current status of trial NCT00583284?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2006-11. Estimated completion is 2008-03.
Who is sponsoring clinical trial NCT00583284?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.